Follow the Medivir AB share price and the full directors' dealings record of the company, a listed equity based in Finland. Shares trade on FI FI, under the supervision of FIN-FSA. Operating in the Health Care sector, Medivir AB has logged 0 public disclosures. Market capitalisation: €1bn. All data is openly available.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
0 of 0 declarations
Medivir AB is a Swedish pharmaceutical company focused on the development of antiviral treatments. It is listed on the Stockholm Stock Exchange under the symbol XSTO.